会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Modified nucleotides and methods of preparing and using same
    • 修饰的核苷酸及其制备和使用方法
    • US4711955A
    • 1987-12-08
    • US496915
    • 1983-05-23
    • David C. WardPennina R. LangerAlexander A. Waldrop, III
    • David C. WardPennina R. LangerAlexander A. Waldrop, III
    • C07H19/167C07H19/173C07H19/20C07H21/00C07H21/02C12P19/34C12Q1/18C12Q1/68C07H17/02C07H19/02C07H19/06
    • C07H19/20C07H21/00C12P19/34C12Q1/18C12Q1/6804C12Q1/6816
    • Compounds having the structure: ##STR1## wherein B represents a purine, 7-deazapurine, or pyrimidine moiety covalently bonded to the C.sup.1' -position of the sugar moiety, provided that when B is purine or 7-deazapurine, it is attached at the N.sup.9 -position of the purine or 7-deazapurine and when B is pyrimidine, it is attached at the N.sup.1 -position;wherein A represents a moiety consisting of at least three carbon atoms which is capable of forming a detectable complex with a polypeptide when the compound is incorporated into a double-stranded ribonucleic acid, deoxyribonucleic acid duplex, or DNA-RNA hybrid;wherein the dotted line represents a chemical linkage joining B and A, provided that if B is purine, the linkage is attached to the 8-position of the purine, if B is 7-deazapurine, the linkage is attached to the 7-position of the deazapurine, and if B is pyrimidine, the linkage is attached to the 5-position of the pyrimidine andwherein each of x, y and z represents ##STR2## either directly, or when incorporated into oligo- and polynucleotides, provide probes which are widely useful.Applications include detection and localization of polynucleotide sequences in chromosomes, fixed cells, tissue sections, and cell extracts. Specific applications include chromosomal karyotyping, clinical diagnosis of nucleic acid-containing etiological agents, e.g. bacteria, viruses, or fungi, and diagnosis of genetic disorders.
    • 具有以下结构的化合物:其中B表示与糖部分的C1'位共价结合的嘌呤,7-脱氮嘌呤或嘧啶部分,条件是当B是嘌呤或7-脱氮嘌呤时,其连接在 嘌呤或7-脱氮嘌呤的N9位,当B为嘧啶时,其连接在N1位; 其中A表示由至少三个碳原子组成的部分,当化合物掺入双链核糖核酸,脱氧核糖核酸双链体或DNA-RNA杂交体时,能够与多肽形成可检测的复合物; 其中虚线表示连接B和A的化学连接,条件是如果B是嘌呤,则如果B是7-脱氮嘌呤,则连接键连接到嘌呤的8-位,连接键连接到嘌呤的7-位 脱氮嘌呤,如果B是嘧啶,则该连接键连接到嘧啶的5-位,并且x,y和z中的每一个直接或当并入寡核苷酸和多核苷酸时 提供广泛有用的探针。 应用包括染色体,固定细胞,组织切片和细胞提取物中多核苷酸序列的检测和定位。 具体应用包括染色体核型分析,含核酸病原体的临床诊断。 细菌,病毒或真菌,以及遗传疾病的诊断。
    • 4. 发明授权
    • Modified nucleotides and polynucleotides and complexes form therefrom
    • 由此形成修饰的核苷酸和多核苷酸和复合物
    • US5476928A
    • 1995-12-19
    • US841910
    • 1992-02-26
    • David C. WardPennina R. LangerAlexander A. Waldrop, III
    • David C. WardPennina R. LangerAlexander A. Waldrop, III
    • C07H19/167C07H19/173C07H19/20C07H21/00C07H21/02C12P19/34C12Q1/18C12Q1/68
    • C07H19/20C07H21/00C12P19/34C12Q1/18C12Q1/6804C12Q1/6816
    • Compounds having the structure: ##STR1## wherein B represents a purine, 7-deazapurine, or pyrimidine moiety covalently bonded to the C.sup.1' -position of the sugar moiety, provided that when B is purine or 7-deazapurine, it is attached at the N.sup.9 -position of the purine or 7-deazapurine and when B is pyrimidine, it is attached at the N.sup.1 -position;wherein A represents a moiety consisting of at least three carbon atoms which is capable of forming a detectable complex with a polypeptide when the compound is incorporated into a double-stranded ribonucleic acid, deoxyribonucleic acid duplex, or DNA-RNA hybrid;wherein the dotted line represents a chemical linkage joining B and A, provided that if B is purine, the linkage is attached to the 8-position of the purine, if B is 7-deazapurine, the linkage is attached to the 7-position of the deazapurine, and if B is pyrimidine, the linkage is attached to the 5-position of the pyrimidine; andwherein each of x, y and z represents ##STR2## either directly, or when incorporated into oligo- and polynucleotides, provide probes which are widely useful.Applications include detection and localization of polynucleotide sequences in chromosomes, fixed cells, tissue sections, and cell extracts. Specific applications include chromosomal karyotyping, clinical diagnosis of nucleic acid-containing etiological agents, e.g. bacteria, viruses, or fungi, and diagnosis of genetic disorders.
    • 具有以下结构的化合物:其中B表示与糖部分的C1'位共价结合的嘌呤,7-脱氮嘌呤或嘧啶部分,条件是当B是嘌呤或7-脱氮嘌呤时,其连接在 嘌呤或7-脱氮嘌呤的N9位,当B为嘧啶时,其连接在N1位; 其中A表示由至少三个碳原子组成的部分,当化合物掺入双链核糖核酸,脱氧核糖核酸双链体或DNA-RNA杂交体时,能够与多肽形成可检测的复合物; 其中虚线表示连接B和A的化学连接,条件是如果B是嘌呤,则如果B是7-脱氮嘌呤,则连接键连接到嘌呤的8-位,连接键连接到嘌呤的7-位 脱氮嘌呤,如果B是嘧啶,则连接键连接到嘧啶的5-位; 并且其中x,y和z中的每一个直接地或当并入寡核苷酸和多核苷酸时提供广泛有用的探针。 应用包括染色体,固定细胞,组织切片和细胞提取物中多核苷酸序列的检测和定位。 具体应用包括染色体核型分析,含核酸病原体的临床诊断。 细菌,病毒或真菌,以及遗传疾病的诊断。
    • 5. 发明授权
    • Modified polynucleotides and methods of preparing same
    • 改性多核苷酸及其制备方法
    • US5449767A
    • 1995-09-12
    • US886660
    • 1992-05-20
    • David C. WardPennina R. LangerAlexander A. Waldrop, III
    • David C. WardPennina R. LangerAlexander A. Waldrop, III
    • C07H19/167C07H19/173C07H19/20C07H21/00C07H21/02C12P19/34C12Q1/18C12Q1/68
    • C07H19/20C07H21/00C12P19/34C12Q1/18C12Q1/6804C12Q1/6816
    • Compounds having the structure: ##STR1## wherein B represents 7-deazapurine, or pyrimidine moiety covalently bonded to the C.sup.1 '-position of the sugar moiety, provided that when B is 7-deazapurine, it is attached at the N.sup.9 -position of the 7-deazapurine and when B is pyrimidine, it is attached at the N.sup.1 -position;wherein A represents a moiety consisting of at least three carbon atoms which is capable of forming a detectable complex with a polypeptide when the compound is incorporated into a double-stranded ribonucleic acid, deoxyribonucleic acid duplex, or DNA-RNA hybrid;wherein the dotted line represents a chemical linkage joining B and A, provided that if B is 7-deazapurine, the linkage is attached to the 7-position of the deazapurine, and if B is pyrimidine, the linkage is attached to the 5-position of the pyrimidine; andwherein each of x, y and z represents ##STR2## either directly, or when incorporated into oligo- and polynucleotides, provide probes which are widely useful.
    • 具有以下结构的化合物:其中B代表7-脱氮嘌呤或与糖部分的C1'位共价结合的嘧啶部分,条件是当B为7-脱氮嘌呤时,其连接在 7-脱氮嘌呤,当B为嘧啶时,其连接在N1位; 其中A表示由至少三个碳原子组成的部分,当化合物掺入双链核糖核酸,脱氧核糖核酸双链体或DNA-RNA杂交体时,能够与多肽形成可检测的复合物; 其中虚线表示连接B和A的化学键,条件是如果B是7-脱氮嘌呤,则连接键连接到脱氮嘌呤的7-位,如果B是嘧啶,则连接键连接到5-位 的嘧啶; 并且其中x,y和z中的每一个直接表示“IMAGE”或“IMAGE”,或者当并入寡核苷酸和多核苷酸时,提供广泛有用的探针。
    • 6. 发明授权
    • Methods of using labeled nucleotides
    • 使用标记核苷酸的方法
    • US5328824A
    • 1994-07-12
    • US130070
    • 1987-12-08
    • David C. WardPennina R. LangerAlexander A. Waldrop, III
    • David C. WardPennina R. LangerAlexander A. Waldrop, III
    • C07H19/167C07H19/173C07H19/20C07H21/00C07H21/02C12P19/34C12Q1/18C12Q1/68
    • C07H19/20C07H21/00C12P19/34C12Q1/18C12Q1/6804C12Q1/6816
    • Compounds having the structure: ##STR1## wherein B represents a purine, 7-deazapurine, or pyrimidine moiety covalently bonded to the C.sup.1' -position of the sugar moiety, provided that when B is purine or 7-deazapurine, it is attached at the N.sup.9 -position of the purine or 7-deazapurine and when B is pyrimidine, it is attached at the N.sup.1 -position;wherein A represents a moiety consisting of at least three carbon atoms which is capable of forming a detectable complex with a polypeptide when the compound is incorporated into a double-stranded ribonucleic acid, deoxyribonucleic acid duplex, or DNA-RNA hybrid;wherein the dotted line represents a chemical linkage joining B and A, provided that if B is purine, the linkage is attached to the 8-position of the purine, if B is 7-deazapurine, the linkage is attached to the 7-position of the deazapurine, and if B is pyrimidine, the linkage is attached to the 5-position of the pyrimidine; andwherein each of x, y and z represents ##STR2## either directly, or when incorporated into oligo- and polynucleotides, provide probes which are widely useful.Applications include detection and localization of polynucleotide sequences in chromosomes, fixed cells, tissue sections, and cell extracts. Specific applications include chromosomal karyotyping, clinical diagnosis of nucleic acid-containing etiological agents, e.g. bacteria, viruses, or fungi, and diagnosis of genetic disorders.
    • 具有以下结构的化合物:其中B表示与糖部分的C1'位共价结合的嘌呤,7-脱氮嘌呤或嘧啶部分,条件是当B是嘌呤或7-脱氮嘌呤时,其连接在 嘌呤或7-脱氮嘌呤的N9位,当B为嘧啶时,其连接在N1位; 其中A表示由至少三个碳原子组成的部分,当化合物掺入双链核糖核酸,脱氧核糖核酸双链体或DNA-RNA杂交体时,能够与多肽形成可检测的复合物; 其中虚线表示连接B和A的化学连接,条件是如果B是嘌呤,则如果B是7-脱氮嘌呤,则连接键连接到嘌呤的8-位,连接键连接到嘌呤的7-位 脱氮嘌呤,如果B是嘧啶,则连接键连接到嘧啶的5-位; 并且其中x,y和z中的每一个直接地或当并入寡核苷酸和多核苷酸时提供广泛有用的探针。 应用包括染色体,固定细胞,组织切片和细胞提取物中多核苷酸序列的检测和定位。 具体应用包括染色体核型分析,含核酸病原体的临床诊断。 细菌,病毒或真菌,以及遗传疾病的诊断。
    • 7. 发明授权
    • Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein
    • 其中使用过氧化物的化学发光测定和化学发光化合物
    • US07718576B2
    • 2010-05-18
    • US10457385
    • 2003-06-10
    • Alexander A. Waldrop, IIICalvin P. H. Vary
    • Alexander A. Waldrop, IIICalvin P. H. Vary
    • C40B30/00
    • C12Q1/28C07D219/04
    • A compound is provided having the formula: where C* is an sp2 coordinated carbon atom; A is defined by the formula wherein R12, R13, R14, R15, R16, R17, R18 and R19 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, aryl, alkylaryl, heteroaryl, heteroalkoxy, aldehyde, keto, amino, nitro, halo, sulfate, sulfonyl, carboxy, carboxyester, phosphate or phosphoester, each of which may be substituted or unsubstituted; Z is a moiety that is covalently bonded to C* selected from the group consisting of O, S, N—R1, and +N—R1R2 where R1 and R2 are selected from hydrogen, alkyl, alkoxy, aryl, alkylaryl, heteroaryl, or heteroalkoxy moieties, each of which may be substituted or unsubstituted; and Q is a suitable leaving group yields a compound which is capable of exhibiting a chemiluminescent reaction in the presence of a peroxide or peroxide-like compound under aqueous or mixed aqueous-organic conditions.
    • 提供具有下式的化合物:其中C *是sp2配位碳原子; A由下式定义:其中R12,R13,R14,R15,R16,R17,R18和R19独立地选自氢,烷基,烷氧基,芳基,烷基芳基,杂芳基,杂烷氧基,醛,酮,氨基, 硝基,卤素,硫酸根,磺酰基,羧基,羧酸酯,磷酸酯或磷酯,它们各自可以是取代或未取代的; Z是与C *共价连接的部分,其选自O,S,N-R 1和+ N-R 1 R 2,其中R 1和R 2选自氢,烷基,烷氧基,芳基,烷基芳基,杂芳基或 杂烷氧基部分,其各自可以是取代或未取代的; 并且Q是合适的离去基团,得到在水溶液或混合水 - 有机条件下能够在过氧化物或过氧化物类化合物存在下显示化学发光反应的化合物。